论文

[1] Yang Q, Ye H, Sun GY, Wang KY, Dai LP, Qiu CP, Shi JX, Zhu JC, Wang X, Wang P. Human Proteome Microarray identifies autoantibodies to tumor-associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma. Molecular Oncology, 2023, 17(5): 887-900.

[2] Li TD, Xia JF , Yun H , Sun GY, Shen YJ , Wang P , Shi JX , Wang KY, Yang HY , Ye H*. A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma.Cancer Cell International (2023) 23:273.(IF+5.48, 中科院二区）

[3] Sun GY, Ye H, Liu HJ, Li TD, Li JX, Zhang XY, Cheng YF, Wang KY, Shi JX , Dai LP, Wang P. ZPR1 is an immunodiagnostic biomarker and promotes tumor progression in esophageal squamous cell carcinoma.Cancer science DOI: 10.1111/cas.16004

[4] Yi C, Li T, Shen Y, Wang P, Dai L, Shi J, Wang K, Sun C and Ye H*. Polymorphisms of nucleotide excision repair genes associated with colorectal cancer risk: Meta-analysis and trial sequential analysis. Front. Genet (2022) 13:1009938.

[5] Wu JY, Wang P, Han Z, Li TD,Yi C,Qiu CP, Yang Q, Sun GY, Dai LP,Shi JX, Wang KY, Ye H*. A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and the autoantibody-antigen system. Cancer science, 2022, Vol.113 (2), p.411-422.

[6] Ren PF , Wang KY, Ma J, Cao XQ, Zhao JZ, Zhao CZ, Guo YJ, Ye H*. Autoantibody Against Ferritin Light Chain is a Serum Biomarker for the Detection of Liver Cirrhosis but Not Liver Cancer. J Hepatocell Carcinoma 2022 Mar 29;9:221-232.

[7] Qiu, CP, Wang, BF, Wang, P ; Wang, X, Ma, Y, Dai, LP, Shi, JX, Wang, KY, Sun, GY, Ye H*, Zhang, JY. Identification of novel autoantibody signatures and evaluation of a panel of autoantibodies in breast cancer. Cancer science, 2021, Vol.112 (8), p.3388-3400.

[8] Zhang H, Yang X, Zhu L, Li Z, Zuo P, Wang P, Feng J, Mi Y, Zhang C, Xu Y, Jin G, Zhang J, Ye H*. ASPM promotes hepatocellular carcinoma progression by activating Wnt/β-catenin signaling through antagonizing autophagy-mediated Dvl2 degradation. FEBS Open Bio 2021.

[9] Ye H, Li TD, Wang H, Wu J, Yi C, Shi J, Wang P, Song C, Dai L, Jiang G, Huang Y, Yu Y, Li J. TSPAN1, TMPRSS4, SDR16C5, and CTSE as Novel Panel for Pancreatic Cancer: A Bioinformatics Analysis and Experiments Validation. Front Immunol 2021,12:649551.

[10]Sun G, Ye H, Wang X, Li T, Jiang D, Qiu C, Dai L, Shi J, Wang K, Song C, Wang P, Zhang J. Autoantibodies against tumor-associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma. Cancer Med 2020,9:1173-1182.

[11] Qiu C, Wang P, Wang B, Shi J, Wang X, Li T, Qin J, Dai L, Ye H*, Zhang J. Establishment and validation of an immunodiagnostic model for prediction of breast cancer. Oncoimmunology 2020,9:1682382

著作

[1]肿瘤学，2016，吉林科学技术出版社，ISBN978-7-5578-0860-0，副主编，

[2]罕见病临床与诊断，2017，清华大学出版社，ISBN978-7-302-46614-7, 编委

[3]河南省第六次国家卫生服务统计调查报告，2022，郑州大学出版社，ISBN978-7-5645-8802-1, 副主编

专利

[1] 一种用于肝癌诊断的生物标志物及检测试剂盒，专利号：ZL 2021 1 1520951.8，叶华（第一发明人）

[2] 一种用于食管鳞癌筛查的ELISA试剂盒，专利号：ZL 2021 1 1088176.3，叶华（第一发明人）